Certified by Founder Lodge
AMILI
Singapore - Central Singapore
START UP
1 Disclosed Funding Rounds $10,500,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AMILI is a precision gut microbiome company based in Singapore serving the region.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 15 ,2022 | Series A | $10,500,000 |
SEEDS Capital
Capital Code
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
